OPORNOŚĆ GRONKOWCÓW ZŁOCISTYCH NA ŚRODKI PRZECIWBAKTERYJNE

Joanna Stefańska

doi:10.56782/pps.42

Published : 2003-08-04

Vol. 1 No. 3 (2003)

STAPHYLOCOCCAL RESISTANCE TO ANTIBACTERIAL AGENTS

Joanna Stefańska

DOI: https://doi.org/10.56782/pps.42

Abstract

Increase of the resistance of S. aureus and other bacteria to antibiotics and remaining antimicrobial agents is an essential problem in medicine. The knowledge of the resistance mechanism and their genetic basis enables the search for new agents (drugs, disinfectants), acting against staphylococci, including multidrug resistance strains, responsible for nosocomial infections.

Keywords:

antibiotics, bacterial resistance, plasmids, S. aureus

Similar Articles

Kacper Jasiński, Paulina Oleksa, Daria Żuraw, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Bartosz Pawłowski, The effectiveness of the immune-boosting preparations in prevention and treatment of respiratory infections , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Magda Izydorczak, Joanna Stefańska, ANTIMICROBIAL AGENT TRICLOSAN - ACTIVITY, APPLICATIONS AND HAZARDS , Prospects in Pharmaceutical Sciences: Vol. 5 No. 2 (2007)
Magdalena Bamburowicz-Klimkowska, Mirosław M. Szutowski, STRATEGIES TO COMBAT MULTIDRUG RESISTANCE OF CANCER , Prospects in Pharmaceutical Sciences: Vol. 10 No. 1 (2012)
Magdalena Bielińska, Grzegorz Nałęcz-Jawecki, PHARMACEUTICALS IN THE ENVIRONMENT. I: EVALUATION OF TOXICITY OF THREE FLUOROQUINOLONES TO DUCKWEED LEMNA MINOR , Prospects in Pharmaceutical Sciences: Vol. 7 No. 4 (2009)
Mateusz Sobczyk, Mikołaj Porzak, Daria Żuraw, Alicja Sodolska, Paulina Oleksa, Kacper Jasiński, Small intestinal bacterial overgrowth – current, novel and possible future methods of treatment and diagnosis , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Arzu Birinci Yildirim, Ayca Cimen, Yavuz Baba, Arzu Turker, Natural- and in vitro-grown Filipendula ulmaria (L.) Maxim: evaluation of pharmaceutical potential (antibacterial, antioxidant and toxicity) and phenolic profiles , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Ewelina Flegiel, Magdalena Piotrowska, Magdalena Ptasznik, Aleksandra Baran, Justyna Lenart, Miłosz Podrażka, Joanna Mazurek, Hubert Stachowicz, Weronika Bartos, Monika Adamczyk, Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Nazan Çömlekçioğlu, Nuh Korkmaz, Mehmet Ali Yüzbaşıoğlu, İmran Uysal, Mustafa Sevindik, Mistletoe (Loranthus europaeus Jacq.): antioxidant, antimicrobial and anticholinesterase activities , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Paulina Oleksa, Daria Żuraw, Kacper Jasiński, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Karolina Haczkur-Pawłowska, Drugs and other chemical substances inducing diabetes – review of the literature , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Anna Dominiczak, Agata Janczak, Martyna Wołek, Katarzyna Mazurek, Maciej Bara, Proton pump inhibitors: prolonged intake and adverse effects , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)

1 2 3 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Stefańska, J. (2003). STAPHYLOCOCCAL RESISTANCE TO ANTIBACTERIAL AGENTS. Prospects in Pharmaceutical Sciences, 1(3), 18–24. https://doi.org/10.56782/pps.42

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

CDC. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR, 2002, 51 (26), 565-567

CDC. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR, 1997, 46 (33), 765

Chien J. W., Kucia M. L., Salata R. A. 2000. Use of linezolid, an oxazolidone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin. Infect. Diseases. 30: 146-151 DOI: https://doi.org/10.1086/313597

De Lencastre H., de Jonge B. L., Matthews P. R., Tomasz A. 1994. Molecular aspects of methicillin resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 33: 7-24 DOI: https://doi.org/10.1093/jac/33.1.7

Dzierżanowska D. Antybiotykoterapia w zakażeniach szpitalnych. W: Zakażenia szpitalne. Red. Dzierżanowska D. Jeljaszewicz J. Alfa-Medica Press 1999. 517-534

Dzierżanowska D., Murawska B. 1998. Rola metycylinoopornych gronkowców (MRSA) w zakażeniach szpitalnych. Terapia 9: 16-19

Firth N., Skurray R. A. 1998. Mobile elements in the evolution and spread of multiple-drug resistance in staphylococci. Drug Resistance Updates. 1: 49-58 DOI: https://doi.org/10.1016/S1368-7646(98)80214-8

Foster T. J. 1983. Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol. Rev. 47:361-409 DOI: https://doi.org/10.1128/mr.47.3.361-409.1983

Gillespie M. T., May W., Skurray R. A. 1986. Plasmid-encoded resistance to acriflavine and qarternary ammonium compounds in methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 34: 47-51 DOI: https://doi.org/10.1111/j.1574-6968.1986.tb01346.x

Hiramatsu K., Hanaki H., Ino T., Tabuta T., Oguri T., Tenover F. C. 1997. Methicillin Resistant Staphylococcus aureus clinical strains with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135-146 DOI: https://doi.org/10.1093/jac/40.1.135

Hsieh P-Ch., Siegel S. A., Rogers B., Davis D., Lewis K. 1998. Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc. Natl. Acad. Sci. USA. 95: 6602-6606 DOI: https://doi.org/10.1073/pnas.95.12.6602

Kaatz G. W., Seo S. M., O'Brien L., Wahiduzzaman M., Foster T. J. 2000. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob. Agents Chemother. 45: 1404-1406 DOI: https://doi.org/10.1128/AAC.44.5.1404-1406.2000

Kaatz G. W., Seo S. M., Ruble Ch.A. 1993. Efflux-mediated fluorochinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37: 1086-1094 DOI: https://doi.org/10.1128/AAC.37.5.1086

Kazama H., Hamashima H., Sasatsu M., Arai T. 1998. Distribution of the antiseptic-resistance gene qacED 1 in Gram-positive bacteria. FEMS Microbiol. Lett. 165: 295-299 DOI: https://doi.org/10.1111/j.1574-6968.1998.tb13160.x

Levy S. B. 1992. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36: 695-703 DOI: https://doi.org/10.1128/AAC.36.4.695

Linares J. 2001. The VISA/GISA problem:therapeutic implications. Clin. Microbiol. Infect. 7 Suppl. 4: 8-15 DOI: https://doi.org/10.1046/j.1469-0691.2001.00054.x

Littlejohn T. G., Rouch D. A., Cram D. S., Di Bernardino D., Skurray A. Molecular and sequence analysis of qacA specifying antiseptic/disinfectant resistance in staphylococci. W: Molecular Biology of the Staphylococci, eds. R.P. Novick. VCH Publishers Inc. 1990, New York, 175-180

Littlejohn T. G., Paulsen I. T., Gillepsie M. T., Tennet J. M., Midgley M., Jones I. G., Purewal A. S., Skurray R. A. 1992. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 95: 259-266 DOI: https://doi.org/10.1111/j.1574-6968.1992.tb05376.x

Livermore D. M. 1995. b -lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584 DOI: https://doi.org/10.1128/CMR.8.4.557

Lyon B. R., Skurray R. A. 1987. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol. Rev. 51: 88-134 DOI: https://doi.org/10.1128/mr.51.1.88-134.1987

Łęski T., Hryniewicz W. 1999. Mupirocyna - natura chemiczna oraz jej zastosowanie w leczeniu zakażeń bakteryjnych. Nowa Klinika. 6: 533-536

McDonnel G., Russell A. D. 1999. Antiseptics and disinfectants: activity, action and resistance. Clin. Microbiol. Rev. 12: 147-179 DOI: https://doi.org/10.1128/CMR.12.1.147

McManus J. 1999. Vancomycin resistant staphylococcus reported in Hong Kong. BMJ, 318, 626 DOI: https://doi.org/10.1136/bmj.318.7184.626

Młynarczyk A., Młynarczyk G., Jeljaszewicz J. 1999. Charakterystyka plazmidów penicylinazowych u szczepów Staphylococcus aureus. Med. Dośw. Mikrobiol. 51: 1-8

Młynarczyk A. Mechanizmy oporności na makrolidy, streptograminy i linkozamidy. Polskie Towarzystwo Farmaceutyczne, Oddział Warszawski, 11 grudzień 2001.

Murray P. R., Rosenthal K. S., Kobayashi G. S., Pfaller M. A. 1998. Medical Microbiology 3rd Edition, 160-168, 175-188

Neyfakh A. A. 1997. Natural functions of bacterial multidrug transporters. Trends Microbiol. 5: 309-313 DOI: https://doi.org/10.1016/S0966-842X(97)01064-0

Neyfakh A. A. 1992. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 36: 484-485 DOI: https://doi.org/10.1128/AAC.36.2.484

Nikaido H. 1996. Multidrug efflux pumps of Gram-negative bacteria. J. Bacteriol. 178: 5853-5859 DOI: https://doi.org/10.1128/jb.178.20.5853-5859.1996

Nikaido H. 1998. Multiple antibiotic resistance and efflux. Curr. Opinion Microbiol. 1: 516-523 DOI: https://doi.org/10.1016/S1369-5274(98)80083-0

Noble W. C., Viarani Z., Cree R. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93, 195-198 DOI: https://doi.org/10.1111/j.1574-6968.1992.tb05089.x

Noguchi N., Hase M., Kitta M., Sasatsu M., Deguchi K., Kono M. 1999. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 172: 247-253 DOI: https://doi.org/10.1111/j.1574-6968.1999.tb13475.x

Novick R.P. 1990. The Staphylococcus as a molecular genetic system. W: Molecular biology of the staphylococci Red. P. Novick, R. A. Skurray. VCH Publishers, Inc. New York, 1-37

Otto M., Gotz F. 2001. ABC transporters of staphylococci. Res. Microbiol. 152 (3-4): 351-6 DOI: https://doi.org/10.1016/S0923-2508(01)01206-2

Pao S. S., Paulsen I. T., Saier M. H. Jr. 1998. Major facilitator superfamily. Microbiol Mol. Biol. Rev. 62: 1-34 DOI: https://doi.org/10.1128/MMBR.62.1.1-34.1998

Paulsen I. T., Brown M. H., Littlejohn T. G., Mitchell B. A., Skurray R. A. 1996. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus; Membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. USA. 93: 3630-3635 DOI: https://doi.org/10.1073/pnas.93.8.3630

Paulsen I. T., Firth N., Skurray R. A. 1997. Resistance to antimicrobial agents other than b -lactams. W: The Staphylococci in human disease. Red. K. B. Crossley, G. L. Archer. Churchill Livington, New York. 175-212

Paulsen I. T., Brown M. H., Skurray R. A. 1996. Proton-dependent multidrug efflux systems. Microbiol Rev. 60: 575-608 DOI: https://doi.org/10.1128/mr.60.4.575-608.1996

Paulsen I. T., Skurray R. A., Tam R., Saier M. H. Jr, Turner R. J., Weiner J. H., Goldberg E. B., Grinius L. L. 1996. The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol. Microbiol. 19: 1167-1175 DOI: https://doi.org/10.1111/j.1365-2958.1996.tb02462.x

Ramsey M. A., Bradley S. F., Kauffman C. A., Morton T. M. 1996. Identification of chromosomal location of mupA gene, encoding lowlewel mupirocin resistance in staphylococcal isolates. Antimicrob. Agents Chemother. 40 (12): 2820-2823 DOI: https://doi.org/10.1128/AAC.40.12.2820

Reverdy M. -E., Bes M., Brun Y., Fleurette J. 1992. Activity of four antiseptics (acriflavine, benzalconium chloride, chlorhexidine digluconate, hexamidine di-isethonate) and of ethidium bromide on 392 strains representing 26 Staphylococcus species. Med. Microbiol. Lett. 1: 56-63.

Reynolds P. E., Fuller C. 1986. Methicillin-resistant strains of Staphylococcusaureus; presence of identical additional penicillin-binding protein in all strains examined. FEMS Microbiol. Lett. 33: 251-254 DOI: https://doi.org/10.1111/j.1574-6968.1986.tb01281.x

Robinson J. B., Tuovinen O. H. 1984. Mechanisms of microbial resistance and detoxification of mercury and organomercury compounds: physiological, biochemical and genetic analyses. Microbiol. Rev. 48: 95-124 DOI: https://doi.org/10.1128/mr.48.2.95-124.1984

Ross J. I., Esdy E. A., Cove J. H., Baumberg S. 1995. Identification of a chromosomaly encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene. 153: 93-98 DOI: https://doi.org/10.1016/0378-1119(94)00833-E

Russell A. D., Maillard J. -Y., Furr J.R. 1998. Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrob. Agents Chemother. 42: 2151 DOI: https://doi.org/10.1128/AAC.42.8.2151

Rybak J. M., Hershberger E., Moldovan T., Grucz R. G. 2000. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob. Agents Chemother. 44: 1062-1066 DOI: https://doi.org/10.1128/AAC.44.4.1062-1066.2000

Sasatsu M., Shibata Y., Noguchi N., Kono M. 1992. High-level resistance to ethidium bromide and antiseptics in Staphylococcus aureus. FEMS Microbiol. Lett. 93: 109-114 DOI: https://doi.org/10.1111/j.1574-6968.1992.tb05075.x

Shaw K. J., Rather P. N., Hare R. S., Miller G. H. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationship of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57: 138-163 DOI: https://doi.org/10.1128/mr.57.1.138-163.1993

Stefańska J. 2000. Występowanie i rozprzestrzenianie się u Staphylococcus aureus determinant oporności na antybiotyki oraz inne związki o aktywności przeciwbakteryjnej. Zakład Mikrobiologii Farmaceutycznej AM w Warszawie. Rozprawa doktorska

Stefańska J., Młynarczyk G., Młynarczyk A., Starościak B., Łuczak M. 2002. Oporność szczepów Staphylococcus aureus na czwartorzędowe sole amoniowe i chlorheksydynę. Med. Dośw. Mikrobiol. 54, 191-197

Suresh J. A. Bitter K., Moreland. T., Raudales F., Diaz-Luna H. 1999. Methicillin resistant Staphylococcus aureus infection in a renal recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment opinions for infections due to resistant organisms. Clin. Infect. Dis. 29: 1341-1342 DOI: https://doi.org/10.1086/313492

Tanaka M., Sato K., Kimura Y., Hayakawa I. 1991. Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Antimicrob. Agents Chemother. 35: 1489-1491 DOI: https://doi.org/10.1128/AAC.35.7.1489

Tennet J. M., Lyon B. R., Midgley M., Jones J. G., Purewal A. S., Skurray R. A. 1989 Physical and chemical characterisation of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J. Gen. Microbiol. 135: 1-10 DOI: https://doi.org/10.1099/00221287-135-1-1

Tracolsomboon S., Danchaivijitr S, Rongrungruang Y., Dhiraputra C., Susaemgrat W., Ito T., Hiramatsu K. 2001. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. JMC, 39, 591-595 DOI: https://doi.org/10.1128/JCM.39.2.591-595.2001

Yamamoto T., Tamura Y., Yokota T. 1988. Antiseptic and antibiotic resistance plasmid in Staphylococcus aureus that possesses ability to confer chlorhexidine and acrinol resistance. Antimicrob. Agents Chemother. 32: 932-93 DOI: https://doi.org/10.1128/AAC.32.6.932

Zarrouk V., Bozdogan B., Leclercq R., Garry L., Carbon C., Fantin B. 2000. Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and experimental endocarditis due to Staphylococcus aureus. Antimicrob. Agents Chemother. 44: 1168-1173 DOI: https://doi.org/10.1128/AAC.44.5.1168-1173.2000

STAPHYLOCOCCAL RESISTANCE TO ANTIBACTERIAL AGENTS

Joanna Stefańska

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Joanna Stefańska